Alina M. Allen

Alina M. Allen, MD is an Associate Professor of Medicine at the Mayo Clinic College of Medicine, specializing in Gastroenterology and Hepatology. As Director of the NAFLD Clinic and Associate Editor for NAFLD at Hepatology, she leads innovative research in nonalcoholic fatty liver disease and its metabolic connections.

• Mayo Clinic, Rochester, MN
• Mayo Clinic College of Medicine
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants

Educational Background:

• MD from Grigore T. Popa University of Medicine and Pharmacy
• M.S. in Clinical and Translational Science from Mayo Graduate School
• Transplant Hepatology and Gastroenterology Fellowships at Mayo Clinic

Research Focus: Dr. Allen's work bridges noninvasive imaging, artificial intelligence, and population health to combat NAFLD/NASH. Key projects include:

• Development of MRE-based biomarkers for early NASH diagnosis
• AI-enabled ECG scoring systems for cirrhosis detection
• Metabolic-liver disease interactions in obesity and diabetes
• Health disparities in liver transplantation access

Publication Trends: Over 107 peer-reviewed works emphasize liver imaging, AI models, and epidemiological frameworks for NAFLD/MASLD.

Scientific Distinctions:

• Future Leaders in NAFLD (2020)
• Vanguard Award for Best Manuscript (2015)
• National Institutes of Health Reviewer Roles
• Global NASH Council Participation

Clinical Leadership: Dr. Allen directs the NAFLD Clinic while serving on multiple editorial and programming committees (AASLD, ACG, CLDF). Her work informs health policy and clinical guidelines for liver disease management.

Labs & Collaborations: Key partnerships include the Center for Cell Signaling in Gastroenterology and Mayo Clinic's Data Analytics Team, focusing on multidisciplinary liver research with cardiologists and data scientists.